News

Indonesia’s BPS has updated KBLI business classification codes, impacting licensing, OSS data, and compliance for regulated sectors.

Vietnam temporarily suspends implementation of stricter registration and import inspection rules for health supplement foods.

The draft 2026 catalogue defines which Class III medical devices would require clinical trial approval before trial initiation.

Learn about the 104 products China’s NMPA admitted into the Special Review Procedure for Innovative Medical Devices in 2025.

China’s NMPA launches a 2026–2028 action plan to strengthen cosmetic manufacturing quality systems, raising compliance expectations.

China’s CNCA revised organic certification rules, tightening inspections, traceability, and post-certification oversight.

GB 4824-2025 aligns China’s EMC rules with CISPR 11:2024 and expands coverage to ISM equipment, robots, and medical electrical devices.

China issues technical guidance clarifying when post-filing updates to new cosmetic raw materials are permitted.

Taiwan issued regulations under the Regenerative Medicine Preparations Act, covering cell sourcing, recruitment, registration, and data retention.

China has issued the Fourth Batch of its Encouraged Generic Drugs Catalogue, opening new market opportunities for pharmaceutical companies.

China’s NMPA updated the Medical Device Classification Catalogue, revising requirements and classifications for 31 product categories.

Vietnam's Decree No. 26/2026/ND-CP” confirms MoH oversight of chemicals in medical devices, IVDs, and medicines.

Hong Kong’s Department of Health introduces Pre-NDA meetings to streamline new drug registrations under the “1+” mechanism.

Guangdong MPA expands GBA Connect Scheme to 71 hospitals, speeding urgent clinical access for Hong Kong and Macau-approved medical products.

The Department of Health has mandated MDACS listing for public procurement eligibility — see which devices are affected and how to prepare.

Indonesia’s Ministry of Health now enforces annual internal audits for medical device distributors under PP No. 28/2025.

Vietnam’s DAV intensifies inspections through March 2026, targeting cosmetic notification compliance and Product Information File readiness.

China’s H1 medical device imports reached approx. USD 24 billion, showing stable demand amid shifts in key categories and sourcing countries.

China signaled a shift in medical device procurement away from price focus, emphasizing clinical use and product quality.

China’s National Health Commission approved 14 new “Three New Foods,” covering novel food raw materials, food additives, and food-related products, with defined compliance conditions for use